<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05092061</url>
  </required_header>
  <id_info>
    <org_study_id>246888</org_study_id>
    <nct_id>NCT05092061</nct_id>
  </id_info>
  <brief_title>Resistance Training in Adults With Obesity</brief_title>
  <official_title>Acute and Chronic Effects of Two Different Types of Resistance Training on Cardiometabolic Health in Adults With Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is two-fold: (1) to assess if two different resistance training&#xD;
      protocols elicit different responses in the acute phase and (2) to assess if the same two&#xD;
      different protocols will elicit different long-term responses on muscular strength, body&#xD;
      composition and cardiometabolic health. The project will include 30 adults with obesity&#xD;
      (defined as BMI ≥ 30 or abdominal obesity according to the International Diabetes&#xD;
      Federation). In the acute phase blood lactate, heart rate, enjoyment and perceived exertion&#xD;
      will be assessed after the two resistance training protocols. In addition, the mean 24-h&#xD;
      blood glucose concentration after exercise will be compared between the two protocols.&#xD;
&#xD;
      For the long-term effects blood markers of cardiometabolic health, blood pressure, body&#xD;
      composition, objectively measured physical activity and physical fitness will be assessed&#xD;
      before and after the intervention. Also, perceived health-related quality of life will be&#xD;
      assessed before and after the intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 14, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study will consist of both a crossover study model (acute phase) and parallel model (chronic phase).</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycated haemoglobin (HbA1c)</measure>
    <time_frame>7 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting glucose</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipid concentration</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic blood pressure</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat</measure>
    <time_frame>7 weeks</time_frame>
    <description>Measured by bioelectrical impedance (InBody 770)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat-free mass</measure>
    <time_frame>7 weeks</time_frame>
    <description>Measured by bioelectrical impedance (InBody 770)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass</measure>
    <time_frame>7 weeks</time_frame>
    <description>Measured by bioelectrical impedance (InBody 770)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visceral fat area</measure>
    <time_frame>7 weeks</time_frame>
    <description>Measured by bioelectrical impedance (InBody 770)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VO2max (maximal aerobic capacity)</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of force development</measure>
    <time_frame>7 weeks</time_frame>
    <description>Measured by Kistler force plate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscular strength (1RM)</measure>
    <time_frame>7 weeks</time_frame>
    <description>Leg press and bench press</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscular endurance</measure>
    <time_frame>7 weeks</time_frame>
    <description>Maximum number of repetitions using 50% of 1-RM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>Baseline (before intervention), 4 and 7 weeks.</time_frame>
    <description>Assessed at three timepoints throughout the intervention using SenseWear armband activity monitors and/or Personal Activity IntelligenceTM (using heart rate monitors and smart phone application).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life</measure>
    <time_frame>7 weeks</time_frame>
    <description>Using the Short-Form 36 survey and Satisfaction with Physical Function and Appearance Survey</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>Moderate-repetition resistance training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants will undergo a full-body resistance training protocol with moderate repetitions (6-12), moderate load (70-85% of 1RM), and moderate rest between sets (60-90s). Training will be undertaken three times per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-repetition resistance training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants will undergo a full-body resistance training protocol with high repetitions (15+), low load (&lt;60% of 1RM), and short rest between sets (30s). Training will be undertaken three times per week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate-repetition resistance training</intervention_name>
    <description>Will undertake resistance training with moderate loads, and moderate repetitions 3 times per week for 7 weeks.</description>
    <arm_group_label>Moderate-repetition resistance training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-repetition resistance training</intervention_name>
    <description>Will undertake resistance training with low loads, and high repetitions 3 times per week for 7 weeks.</description>
    <arm_group_label>High-repetition resistance training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Obesity (BMI ≥ 30) or&#xD;
&#xD;
          -  Central obesity (defined according to the International Diabetes Federation).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unstable angina&#xD;
&#xD;
          -  recent cardiac infarction (last 4 weeks)&#xD;
&#xD;
          -  uncompensated heart failure&#xD;
&#xD;
          -  severe valvular illness&#xD;
&#xD;
          -  pulmonary disease&#xD;
&#xD;
          -  uncontrolled hypertension&#xD;
&#xD;
          -  kidney failure&#xD;
&#xD;
          -  orthopaedic/neurological limitations&#xD;
&#xD;
          -  cardiomyopathy&#xD;
&#xD;
          -  planned operations during the research period&#xD;
&#xD;
          -  participation in a parallel study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Øystein Risa</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonathan Berg, PhD</last_name>
    <phone>+4745205565</phone>
    <email>jonathan.berg@ntnu.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arnt Erik Tjønna, PhD</last_name>
    <phone>+4741927885</phone>
    <email>arnt.e.tjonna@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Circulation and Medical Imaging</name>
      <address>
        <city>Trondheim</city>
        <zip>7491</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Berg, MSc</last_name>
      <phone>+47 45205565</phone>
      <email>jonathan.berg@ntnu.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 20, 2021</study_first_submitted>
  <study_first_submitted_qc>October 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise therapy</keyword>
  <keyword>Muscular strength</keyword>
  <keyword>Resistance training</keyword>
  <keyword>Fitness testing</keyword>
  <keyword>Healthy lifestyle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

